RxDoctor Payments Data

James Ogilvie, MD

Colon & Rectal Surgery · Grand Rapids, MINPI 1467409029

Payments from drug & device makers

What this record shows

This record is dominated by education: $7,680 of the $12,764 with a category attached, or 60.2%. Cook Biotech Incorporated accounts for 66.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $8,527 and has fallen 99.6% since, to $38 in 2025.

$12,764in general payments, 2019–2025

Across 15 payments — averaging $850.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cook Biotech Incorporated$9K
  • Cook Incorporated$3K
  • Cook Medical LLC$527
  • Si-bone, Inc.$140
  • Medtronic$127
  • Heron Therapeutics, Inc.$78
  • plus $165 from 5 others
$47,208in research payments, 2019–2025

Across 9 payments — averaging $5245.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ethicon Endo-surgery Inc.$47K

What the payments were for

  • Speaking & faculty fees$3,20025%
  • Travel & lodging$1,2099%
  • Food & beverage$6755%
  • Education$7,68060%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,764 in reported general payments places this provider in the 80th percentile of 72 colon & rectal surgery providers in Michigan.

See all colon & rectal surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$49,519
Medicare patients
111
Services billed
208

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg129$3,199
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine37$1,459
Dicyclomine Hcl19$632
Neomycin Sulfate30$164
Baclofen12$129
Metronidazole40$110
Gabapentin20$105
Diazepam34$42
Ciprofloxacin Hcl13$29
Oxycodone Hcl11$26

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →